1. Management is doing what it can by constantly attending investor presentations, like the one next Wednesday night. That helps get the story out there. 2. The stock's recent demise is similar to many or most other small cap biotechs. People got out of small cap funds during this "crash". They all get beat regardless of how good they may or may not be. 3. The patent infringement lawsuit is a big overhang to the stock. If they win, it's more than a double, but even they have said that it is very difficult to get these type of court actions reversed. So, they are not counting on winning. If it is announced that they have lost, the stock could go down another 10 to 15% temporarily. People hate it when I write the truth. I was basically told to go f**k myself when I wrote about this 3 months ago. 4. The stock value should be significantly higher than it is right now, with an FDA filing right around the corner and a BLA filing in 2012. They don't need to win the patent suit to be worth $5.50 twelve months from now. 5. Happy Friday everyone! Our turn will come.